Table of Contents
1. Methodology and Scope
1.1. Methodology
1.1.1. Initial data exploration
1.1.2. Statistical model and forecast
1.1.3. Industry insights and validation
1.1.4. Definitions forecast parameters
1.2. Data sources
1.2.1. Secondary
1.2.2. Primary
2 Market Overview
2.1 Dermatological Disorders Medications Introduction
2.2 Market Analysis by Type
2.2.1 Prescription Drugs
2.2.2 Over-The-Counter Drugs
2.3 Market Analysis by Applications
2.3.1 Hospital Pharmacies
2.3.2 Online Pharmacies
2.3.3 Retail Pharmacies
2.4 Market Analysis by Countries
2.4.1 South Africa Status and Prospect (2014-2026)
2.4.2 Egypt Status and Prospect (2014-2026)
2.4.3 Nigeria Status and Prospect (2014-2026)
2.5 Market Dynamics
2.5.1 Market Opportunities
2.5.2 Market Risk
2.5.3 Market Driving Force
2.6 Market Competition News and Trend
2.6.1 Merger, Consolidation or Acquisition News
2.6.2 Investment or Disinvestment News
2.6.3 New Product Development and Launch
3 Africa Dermatological Disorders Medications Market Competition, by Manufacturer
3.1 Africa Dermatological Disorders Medications Sales and Market Share by Manufacturer (2016-2018)
3.1.1 Africa Dermatological Disorders Medications Sales by Manufacturer (2016-2018)
3.1.2 Africa Dermatological Disorders Medications Sales Market Share by Manufacturer (2016-2018)
3.2 Africa Dermatological Disorders Medications Revenue and Market Share by Manufacturer (2016-2018)
3.2.1 Africa Dermatological Disorders Medications Revenue by Manufacturer (2016-2018)
3.2.2 Africa Dermatological Disorders Medications Revenue Market Share by Manufacturer (2016-2018)
3.3 Africa Dermatological Disorders Medications Price by Manufacturers (2016-2018)
3.4 Market Concentration Rate
3.4.1 Top 3 Dermatological Disorders Medications Manufacturer Market Share
3.4.2 Top 5 Dermatological Disorders Medications Manufacturer Market Share
3.5 Market Competition Trend
4 Manufacturers Profiles
4.1 Mylan Pharmaceuticals
4.1.1 Business Overview
4.1.2 Dermatological Disorders Medications Type and Applications
4.1.2.1 Production A
4.1.2.2 Production B
4.1.3 Mylan Pharmaceuticals Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.2 Pfizer
4.2.1 Business Overview
4.2.2 Dermatological Disorders Medications Type and Applications
4.2.2.1 Production A
4.2.2.2 Production B
4.2.3 Pfizer Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.3 Roche
4.3.1 Business Overview
4.3.2 Dermatological Disorders Medications Type and Applications
4.3.2.1 Production A
4.3.2.2 Production B
4.3.3 Roche Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.4 Almirall
4.4.1 Business Overview
4.4.2 Dermatological Disorders Medications Type and Applications
4.4.2.1 Production A
4.4.2.2 Production B
4.4.3 Almirall Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.5 Bausch Health
4.5.1 Business Overview
4.5.2 Dermatological Disorders Medications Type and Applications
4.5.2.1 Production A
4.5.2.2 Production B
4.5.3 Bausch Health Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.6 Barrier Therapeutics
4.6.1 Business Overview
4.6.2 Dermatological Disorders Medications Type and Applications
4.6.2.1 Production A
4.6.2.2 Production B
4.6.3 Barrier Therapeutics Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.7 PharmaDerm
4.7.1 Business Overview
4.7.2 Dermatological Disorders Medications Type and Applications
4.7.2.1 Production A
4.7.2.2 Production B
4.7.3 PharmaDerm Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.8 Bristol-Myers Squibb
4.8.1 Business Overview
4.8.2 Dermatological Disorders Medications Type and Applications
4.8.2.1 Production A
4.8.2.2 Production B
4.8.3 Bristol-Myers Squibb Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.9 Galderma
4.9.1 Business Overview
4.9.2 Dermatological Disorders Medications Type and Applications
4.9.2.1 Production A
4.9.2.2 Production B
4.9.3 Galderma Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.10 GlaxoSmithKline
4.10.1 Business Overview
4.10.2 Dermatological Disorders Medications Type and Applications
4.10.2.1 Production A
4.10.2.2 Production B
4.10.3 GlaxoSmithKline Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.11 Novartis
4.11.1 Business Overview
4.11.2 Dermatological Disorders Medications Type and Applications
4.11.2.1 Production A
4.11.2.2 Production B
4.11.3 Novartis Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.12 Sinclair Pharma
4.12.1 Business Overview
4.12.2 Dermatological Disorders Medications Type and Applications
4.12.2.1 Production A
4.12.2.2 Production B
4.12.3 Sinclair Pharma Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
5 Africa Dermatological Disorders Medications Market Analysis by Countries
5.1 Africa Dermatological Disorders Medications Sales and Market Share by Countries (2014-2018)
5.1.1 Africa Dermatological Disorders Medications Sales by Countries (2014-2018)
5.1.2 Africa Dermatological Disorders Medications Sales Market Share by Countries (2014-2018)
5.2 Africa Dermatological Disorders Medications Revenue (Value) and Market Share by Countries (2014-2018)
5.2.1 Africa Dermatological Disorders Medications Revenue by Countries (2014-2018)
5.2.2 Africa Dermatological Disorders Medications Revenue Market Share by Countries (2014-2018)
6 Africa Market Segmentation Dermatological Disorders Medications by Type
6.1 Africa Dermatological Disorders Medications Sales, Revenue and Market Share by Type (2014-2018)
6.1.1 Africa Dermatological Disorders Medications Sales and Market Share by Type (2014-2018)
6.1.2 Africa Dermatological Disorders Medications Revenue and Market Share by Type (2014-2018)
6.2 Prescription Drugs Sales Growth Rate and Price (2014-2018)
6.2.1 Africa Prescription Drugs Sales Growth Rate (2014-2018)
6.2.2 Africa Prescription Drugs Price (2014-2018)
6.3 Over-The-Counter Drugs Sales Growth Rate and Price (2014-2018)
6.3.1 Africa Over-The-Counter Drugs Sales Growth Rate (2014-2018)
6.3.2 Africa Over-The-Counter Drugs Price (2014-2018)
7 Africa Market Segmentation Dermatological Disorders Medications by Application
7.1 Africa Dermatological Disorders Medications Sales Market Share by Application (2014-2018)
7.2 Hospital Pharmacies Sales Growth Rate (2014-2018)
7.3 Online Pharmacies Sales Growth Rate (2014-2018)
7.4 Retail Pharmacies Sales Growth Rate (2014-2018)
8 South Africa Dermatological Disorders Medications Sales, Revenue, by Type, Application and Manufacturers
8.1 South Africa Dermatological Disorders Medications Revenue, Sales and Growth Rate (2014-2018)
8.2 South Africa Dermatological Disorders Medications Sales and Market Share by Type
8.2.1 South Africa Dermatological Disorders Medications Sales by Type (2014-2018)
8.2.2 South Africa Dermatological Disorders Medications Sales Market Share by Type (2014-2018)
8.3 South Africa Dermatological Disorders Medications Sales and Market Share by Application (2014-2018)
8.3.1 South Africa Dermatological Disorders Medications Sales by Application (2014-2018)
8.3.2 South Africa Dermatological Disorders Medications Sales Market Share by Application (2014-2018)
8.4 South Africa Dermatological Disorders Medications Sales, Revenue and Market Share by Manufacturer (2016-2018)
8.4.1 South Africa Dermatological Disorders Medications Sales and Market Share by Manufacturer (2016-2018)
8.4.2 South Africa Dermatological Disorders Medications Revenue and Market Share by Manufacturer (2016-2018)
8.5 South Africa Dermatological Disorders Medications Export and Import (2014-2018)
9 Nigeria Dermatological Disorders Medications Sales, Revenue, by Type, Application and Manufacturers
9.1 Nigeria Dermatological Disorders Medications Revenue, Sales and Growth Rate (2014-2018)
9.2 Nigeria Dermatological Disorders Medications Sales and Market Share by Type (2014-2018)
8.2.1 Nigeria Dermatological Disorders Medications Sales by Type (2014-2018)
9.2.2 Nigeria Dermatological Disorders Medications Sales Market Share by Type (2014-2018)
9.3 Nigeria Dermatological Disorders Medications Sales and Market Share by Application (2014-2018)
9.3.1 Nigeria Dermatological Disorders Medications Sales by Application (2014-2018)
9.3.2 Nigeria Dermatological Disorders Medications Sales Market Share by Application (2014-2018)
9.4 Nigeria Dermatological Disorders Medications Sales, Revenue and Market Share by Manufacturer (2016-2018)
9.4.1 Nigeria Dermatological Disorders Medications Sales and Market Share by Manufacturer (2016-2018)
9.4.2 Nigeria Dermatological Disorders Medications Revenue and Market Share by Manufacturer (2016-2018)
9.5 Nigeria Dermatological Disorders Medications Export and Import (2014-2018)
10 Egypt Dermatological Disorders Medications Sales, Revenue, by Type, Application and Manufacturers
10.1 Egypt Dermatological Disorders Medications Revenue, Sales and Growth Rate (2014-2018)
10.2 Egypt Dermatological Disorders Medications Sales and Market Share by Type (2014-2018)
10.2.1 Egypt Dermatological Disorders Medications Sales by Type (2014-2018)
10.2.2 Egypt Dermatological Disorders Medications Sales Market Share by Type (2014-2018)
10.3 Egypt Dermatological Disorders Medications Sales and Market Share by Application (2014-2018)
10.3.1 Egypt Dermatological Disorders Medications Sales by Application (2014-2018)
10.3.2 Egypt Dermatological Disorders Medications Sales Market Share by Application (2014-2018)
10.4 Egypt Dermatological Disorders Medications Sales, Revenue and Market Share by Manufacturer (2016-2018)
10.4.1 Egypt Dermatological Disorders Medications Sales and Market Share by Manufacturer (2016-2018)
10.4.2 Egypt Dermatological Disorders Medications Revenue and Market Share by Manufacturer (2016-2018)
10.5 Egypt Dermatological Disorders Medications Export and Import (2014-2018)
11 Dermatological Disorders Medications Market Forecast (2019-2026)
11.1 Africa Dermatological Disorders Medications Sales, Revenue and Growth Rate (2019-2026)
11.2 Dermatological Disorders Medications Market Forecast by Countries (2019-2026)
11.2.1 Africa Dermatological Disorders Medications Sales Forecast by Countries (2019-2026)
11.2.2 South Africa Dermatological Disorders Medications Forecast (2019-2026)
11.2.3 Nigeria Dermatological Disorders Medications Forecast (2019-2026)
11.2.4 Egypt Dermatological Disorders Medications Forecast (2019-2026)
11.3 Dermatological Disorders Medications Market Forecast by Type (2019-2026)
11.3.1 Africa Dermatological Disorders Medications Sales Forecast by Type (2019-2026)
11.3.2 Africa Dermatological Disorders Medications Market Share Forecast by Type (2019-2026)
11.4 Dermatological Disorders Medications Market Forecast by Application (2019-2026)
11.4.1 Africa Dermatological Disorders Medications Sales Forecast by Application (2019-2026)
11.4.2 Africa Dermatological Disorders Medications Market Share Forecast by Application (2019-2026)
12 Dermatological Disorders Medications Manufacturing Cost Analysis
12.1 Dermatological Disorders Medications Key Raw Materials Analysis
12.1.1 Key Raw Materials
12.1.2 Price Trend of Key Raw Materials
12.1.3 Key Suppliers of Raw Materials
12.1.4 Market Concentration Rate of Raw Materials
12.2 Proportion of Manufacturing Cost Structure
12.2.1 Raw Materials
12.2.2 Labor Cost
12.2.3 Manufacturing Expenses
12.3 Manufacturing Process Analysis of Dermatological Disorders Medications
13 Industrial Chain, Sourcing Strategy and Downstream Buyers
13.1 Dermatological Disorders Medications Industrial Chain Analysis
13.2 Upstream Raw Materials Sourcing
13.3 Raw Materials Sources of Dermatological Disorders Medications Major Manufacturers in 2018
13.4 Downstream Buyers
14 Sales Channel, Distributors, Traders and Dealers
14.1 Sales Channel
14.1.1 Direct Marketing
14.1.2 Indirect Marketing
14.1.3 Marketing Channel Future Trend
14.2 Market Positioning
14.2.1 Pricing Strategy
14.2.2 Brand Strategy
14.2.3 Target Client
14.3 Distributors, Traders and Dealers
15 Research Findings and Conclusion